Literature DB >> 18252239

Familial aggregation of age-related macular degeneration in the Utah population.

Ling Luo1, Jennifer Harmon, Xian Yang, Haoyu Chen, Shrena Patel, Geraldine Mineau, Zhenglin Yang, Ryan Constantine, Jeanette Buehler, Yuuki Kaminoh, Xiang Ma, Tien Y Wong, Maonian Zhang, Kang Zhang.   

Abstract

We examined familial aggregation and risk of age-related macular degeneration in the Utah population using a population-based case-control study. Over one million unique patient records were searched within the University of Utah Health Sciences Center and the Utah Population Database (UPDB), identifying 4764 patients with AMD. Specialized kinship analysis software was used to test for familial aggregation of disease, estimate the magnitude of familial risks, and identify families at high risk for disease. The population-attributable risk (PAR) for AMD was calculated to be 0.34. Recurrence risks in relatives indicate increased relative risks in siblings (2.95), first cousins (1.29), second cousins (1.13), and parents (5.66) of affected cases. There were 16 extended large families with AMD identified for potential use in genetic studies. Each family had five or more living affected members. The familial aggregation of AMD shown in this study exemplifies the merit of the UPDB and supports recent research demonstrating significant genetic contribution to disease development and progression.

Entities:  

Mesh:

Year:  2008        PMID: 18252239     DOI: 10.1016/j.visres.2007.11.013

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  9 in total

Review 1.  Current gene discovery strategies for ocular conditions.

Authors:  Priya Duggal; Grace Ibay; Alison P Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 2.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

Review 3.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

4.  Evaluation of record linkage between a large healthcare provider and the Utah Population Database.

Authors:  Scott L DuVall; Alison M Fraser; Kerry Rowe; Alun Thomas; Geraldine P Mineau
Journal:  J Am Med Inform Assoc       Date:  2011-09-16       Impact factor: 4.497

5.  Progression of geographic atrophy and genotype in age-related macular degeneration.

Authors:  Michael L Klein; Frederick L Ferris; Peter J Francis; Anne S Lindblad; Emily Y Chew; Sara C Hamon; Jurg Ott
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

6.  Inhibition of cell proliferation and migration after HTRA1 knockdown in retinal pigment epithelial cells.

Authors:  Xueting Pei; Kai Ma; Jun Xu; Ningli Wang; Ningpu Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-31       Impact factor: 3.117

Review 7.  The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application.

Authors:  Peter Charbel Issa; N Victor Chong; Hendrik P N Scholl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-12-03       Impact factor: 3.117

8.  Genetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration.

Authors:  Ewelina Synowiec; Magdalena Pogorzelska; Janusz Blasiak; Jerzy Szaflik; Jacek Pawel Szaflik
Journal:  Mol Biol Rep       Date:  2012-02-14       Impact factor: 2.316

9.  Comparison of machine learning tools for the prediction of AMD based on genetic, age, and diabetes-related variables in the Chinese population.

Authors:  Shaofeng Hao; Junye Bai; Huimin Liu; Lijun Wang; Tao Liu; Chaobin Lin; Xiangguang Luo; Junhui Gao; Jiangman Zhao; Huilin Li; Hui Tang
Journal:  Regen Ther       Date:  2020-09-29       Impact factor: 3.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.